Episode 44

For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:

  • Introduction (0:00)
  • Overview of Antibody-Drug Conjugates (ADCs) (2:07)
  • Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23)
  • Currently Available ADCs for Gynecologic Cancer Management (26:37)
  • Currently Available ADCs for Lung Cancer Management (44:07)
  • Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55)
  • Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07)
  • Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01)

NCPD information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Lung Cancer Update
Lung Cancer Update
This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Listen for free